Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
E. Lee Bendekgey currently holds 238,486 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, E. Lee Bendekgey has been a net seller of ABIO stock. They have purchased $0 and sold $5.0M worth of shares.
E. Lee Bendekgey's most recent insider trade was on Jul 13, 2020, when they sold 7,325 shares at $33.07 per share.
E. Lee Bendekgey serves as Executive at ARCA biopharma, Inc. (ABIO). They have executed 39 insider transactions totaling $5.0M over their tenure at the company.
E. Lee Bendekgey holds the position of Executive at ARCA biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
E. Lee Bendekgey has shown a selling trading pattern, with $0 in total purchases and $5.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by E. Lee Bendekgey was on Feb 26, 2020, when they sold $1.9M worth of NVTA shares. This transaction involved 91,432 shares at $20.58 per share.
E. Lee Bendekgey currently owns 238,486 shares of ARCA biopharma, Inc. (ABIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of E. Lee Bendekgey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. E. Lee Bendekgey has 39 Form 4 filings on record as an insider at ARCA biopharma, Inc..
Set alerts for E. Lee Bendekgey and 40,000+ other insiders.